Neuromedin U: A Small Peptide in the Big World of Cancer
Neuromedin U (NMU), a neuropeptide isolated from porcine spinal cord and named because of its activity as a rat uterus smooth muscle contraction inducer, is emerging as a new player in the tumorigenesis and/or metastasis of many types of cancers. Expressed in a variety of tissues, NMU has been shown...
Main Authors: | Patrycja Przygodzka, Kamila Soboska, Ewelina Sochacka, Joanna Boncela |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-09-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/11/9/1312 |
Similar Items
-
Neuromedin U secreted by colorectal cancer cells promotes a tumour-supporting microenvironment
by: Patrycja Przygodzka, et al.
Published: (2022-12-01) -
Neuromedin U induces an invasive phenotype in CRC cells expressing the NMUR2 receptor
by: Patrycja Przygodzka, et al.
Published: (2021-09-01) -
Examining the Role of Hypothalamus-Derived Neuromedin-U (NMU) in Bone Remodeling of Rats
by: Gabriella Born-Evers, et al.
Published: (2023-03-01) -
The neuromedin U system: Pharmacological implications for the treatment of obesity and binge eating behavior
by: Luca Botticelli, et al.
Published: (2023-09-01) -
Erratum: Neuromedin U: A Small Peptide in the Big World of Cancer. <i>Cancers</i> 2019, <i>11</i>, 1312
by: Patrycja Przygodzka, et al.
Published: (2020-01-01)